{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:26:31Z","timestamp":1791941191750,"version":"4.3.4"},"reference-count":38,"publisher":"Universidad Nacional de Colombia","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. salud p\u00fablica"],"abstract":"<jats:p>Objetivo Determinar la utilidad del fenotipo hipertensi\u00f3n-obesidad abdominal como\u00a0indicador de disglucemia y resistencia a la insulina.\nMaterial y M\u00e9todos Estudio descriptivo transversal con 964 personas adultas (449 mujeres y 515 hombres), que asistieron al Instituto de Endocrinolog\u00eda con riesgo de diabetes mellitus. Se analizaron variables demogr\u00e1ficas (edad, sexo, color de la piel), cl\u00ednicas (tensi\u00f3n arterial y Acantosis nigricans), antropom\u00e9tricas (peso, talla, circunferencia de la cintura e i\u0301ndice de masa corporal) y de laboratorio (glucemia basal y estimulada con la prueba de tolerancia a la glucosa oral e insulinemia). Se calcul\u00f3 el \u00edndice de resistencia a la insulina. El fenotipo hipertensi\u00f3n-obesidad abdominal se defini\u00f3 como la presencia de presi\u00f3n sist\u00f3lica \u2265130 mm Hg o presio\u0301n diast\u00f3lica \u226580 mm Hg o hipertensi\u00f3n arterial tratada, circunferencia de cintura \u226580 cm en mujeres y \u226590 cm en hombres. Se calcul\u00f3 la sensibilidad, la especificidad y los valores predictivos del fenotipo hipertensi\u00f3n obesidad abdominal para identificar disglucemia y resistencia a la insulina.\nResultados Los individuos con el fenotipo hipertensi\u00f3n-obesidad abdominal mostraron mayor proporci\u00f3n de alteraciones del metabolismo de la glucosa y de resistencia a la insulina que las personas sin el fenotipo (p&lt;0,0001). El fenotipo hipertensi\u00f3n-obesidad abdominal identifica mejor a personas con presencia de prediabetes doble, diabetes mellitus y resistencia a la insulina, pues muestran sensibilidades altas (85,9%, 77,5%, y 68,9%, respectivamente) y valores predictivos negativos altos (97,9%, 95,8%, y 74,0%, respectivamente).\nConclusiones El fenotipo hipertensi\u00f3n-obesidad abdominal es una opci\u00f3n sencilla, \u00fatil para identificar a personas con disglucemia y resistencia a la insulina.<\/jats:p>","DOI":"10.15446\/rsap.v25n6.110831","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:36:58Z","timestamp":1728304618000},"page":"1-9","source":"Crossref","is-referenced-by-count":2,"title":["Fenotipo hipertensi\u00f3n-obesidad abdominal como indicador de disglucemia y resistencia a la insulina","Hypertension-abdominal obesity phenotype as an indicator of dysglycaemia and insulin resistance"],"prefix":"10.15446","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-1730","authenticated-orcid":false,"given":"Eduardo","family":"Cabrera Rode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-7085","authenticated-orcid":false,"given":"Brayam Javier","family":"Loaiza Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-8127","authenticated-orcid":false,"given":"Janet","family":"Rodr\u00edguez Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-4183","authenticated-orcid":false,"given":"Ileana","family":"Cubas Due\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-5896","authenticated-orcid":false,"given":"Jos\u00e9","family":"Hern\u00e1ndez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-5731","authenticated-orcid":false,"given":"Oscar","family":"D\u00edaz D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6146","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"2290472","doi-asserted-by":"crossref","unstructured":"M\u00fcller TD, Bl\u00fcher M, Tsch\u00f6p MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022; 21(3):201-23. https:\/\/doi.org\/10.1038\/s41573-021-00337-8.","DOI":"10.1038\/s41573-021-00337-8"},{"key":"2290473","doi-asserted-by":"crossref","unstructured":"Zhang P, Sun X, Jin H, Zhang F-L, Guo Z-N, Yang Y. Association between obesity type and common vascular and metabolic diseases: A cross-sectional study. Front Endocrinol (Lausanne). 2019;10:900. http:\/\/dx.doi.org\/10.3389\/fendo.2019.00900.","DOI":"10.3389\/fendo.2019.00900"},{"key":"2290474","doi-asserted-by":"crossref","unstructured":"Oussaada SM, van Galen KA, Cooiman MI, Kleinendorst L, Hazebroek EJ, van Haelst MM, et al. The pathogenesis of obesity. Metabolism. 2019; 92:26-36. https:\/\/doi.org\/10.1016\/j.metabol.2018.12.012.","DOI":"10.1016\/j.metabol.2018.12.012"},{"key":"2290475","doi-asserted-by":"crossref","unstructured":"Choi D, Choi S, Son JS, Oh SW, Park SM. Impact of discrepancies in general and abdominal obesity on major adverse cardiac events. J Am Heart Assoc. 2019; 8(18):e013471. https:\/\/do.org\/10.1161\/JAHA.119.013471.","DOI":"10.1161\/JAHA.119.013471"},{"key":"2290476","doi-asserted-by":"crossref","unstructured":"Wang Y, Howard AG, Adair LS, Wang H, Avery CL, Gordon-Larsen P. Waist circumference change is associated with blood pressure change independent of BMI change. Obesity (Silver Spring). 2020; 28(1):146- 53. https:\/\/doi.org\/10.1002\/oby.22638.","DOI":"10.1002\/oby.22638"},{"key":"2290477","doi-asserted-by":"crossref","unstructured":"Coutinho T, Goel K, Corr\u00eaa de S\u00e1 D, Carter RE, Hodge DO, Kragelund C, et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of \u201cnormal weight central obesity\u201d. J Am Coll Cardiol. 2013; 61(5):553-60. https:\/\/doi.org\/10.1016\/j.jacc.2012.10.035.","DOI":"10.1016\/j.jacc.2012.10.035"},{"key":"2290478","doi-asserted-by":"crossref","unstructured":"Kim HY, Kim JK, Shin GG, Han JA, Kim JW. Association between abdominal obesity and cardiovascular risk factors in adults with normal body mass index: Based on the sixth Korea national health and nutrition examination survey. J Obes Metab Syndr. 2019; 28(4):262-70. http:\/\/dx.doi.org\/10.7570\/jomes.2019.28.4.262.","DOI":"10.7570\/jomes.2019.28.4.262"},{"key":"2290479","doi-asserted-by":"crossref","unstructured":"Sangr\u00f3s FJ, Torrecilla J, Gir\u00e1ldez-Garc\u00eda C, Carrillo L, Mancera J, Mur T, et al. Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS Study. Rev Esp Cardiol (Engl Ed). 2018; 71(3):170-7. English, Spanish. https:\/\/dx.doi.org\/10.1016\/j.rec.2017.04.035.","DOI":"10.1016\/j.rec.2017.04.035"},{"key":"2290480","unstructured":"Di\u00e9guez-Mart\u00ednez M, Miguel-Soca PE, Rodr\u00edguez-Hern\u00e1ndez R, L\u00f3pez-B\u00e1ster J, Ponce-de Le\u00f3n D. Prevalencia de obesidad abdominal y factores de riesgo cardiovascular asociados en adultos j\u00f3venes. Rev Cubana Salud P\u00fablica [Internet]. 2017 [citado 2022 Mayo 14]; 43(3):1- 16. Disponible en: https:\/\/bit.ly\/49SGSev."},{"key":"2290481","doi-asserted-by":"crossref","unstructured":"Ribeiro FB, de C\u00e1ssia da Silva C, Vasques ACJ, Zambon MP, De Bernardi Rodrigues AM, Camilo DF, et al. Hypertriglyceridemic waist phenotype indicates insulin resistance in adolescents: validation study front hyperglycemic clamp-Brazilian Metabolic Syndrome Study (BRAMS). Diabetol Metab Syndr. 2015; 7 Suppl 1:A145. http:\/\/dx.doi.org\/10.1186\/1758-5996-7-s1-a145.","DOI":"10.1186\/1758-5996-7-S1-A145"},{"key":"2290482","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Santana MV, Su\u00e1rez-P\u00e9rez EL, Ortiz-Mart\u00ednez AP, Guzm\u00e1n-Serrano M, P\u00e9rez-Cardona CM. Association between the hypertriglyce-ridemic waist phenotype, prediabetes, and diabetes mellitus among adults in Puerto Rico. J Immigr Minor Health. 2016; 18(1):102-9. https:\/\/doi.org\/10.1007\/s10903-014-9985-y.","DOI":"10.1007\/s10903-014-9985-y"},{"key":"2290483","doi-asserted-by":"crossref","unstructured":"Chen S, Guo X, Yu S, Yang H, Sun G, Li Z, et al. Hypertriglyceridemic waist phenotype and metabolic abnormalities in hypertensive adults: A STROBE compliant study. Medicine (Baltimore). 2016; 95(49):e5613. http:\/\/dx.doi.org\/10.1097\/MD.0000000000005613.","DOI":"10.1097\/MD.0000000000005613"},{"key":"2290484","doi-asserted-by":"crossref","unstructured":"Nita C, Hancu N, Rusu A, Bala C, Roman G. Hypertensive waist: first step of the screening for metabolic syndrome. Metab Syndr Relat Disord. 2009; 7:105-10. https:\/\/doi.org\/10.1089\/met.2008.0039.","DOI":"10.1089\/met.2008.0039"},{"key":"2290485","doi-asserted-by":"crossref","unstructured":"Cabrera-Rode E, Borja Coronel AC, Montes de Oca-Somoano R, Rodr\u00edguez-Acosta J, Cubas-Due\u00f1as I, Arnold-Dom\u00ednguez Y, et al. Utilidad del fenotipo hipertensi\u00f3n-obesidad abdominal para identificar perso- nas con s\u00edndrome metab\u00f3lico. Revista ALAD. 2020 [citado 2022 Mayo 14]; 10(4). Disponible en: https:\/\/bit.ly\/42Vp6VS.","DOI":"10.24875\/ALAD.20000413"},{"key":"2290486","unstructured":"Parl\u00e1-Sardi\u00f1as J, Cabrera-Rode E, Rodr\u00edguez-Acosta J, Cubas-Due\u00f1as I, Arnold-Dom\u00ednguez Y, Hern\u00e1ndez-Rodr\u00edguez J et al. Utilidad del fenotipo hipertensi\u00f3n-obesidad abdominal para identificar personas con riesgo cardiovascular global moderado y alto. Rev Cubana Endocrinol [Internet]. 2020 [citado 2022 Mayo 14]; 31(3):e248. Disponible en: https:\/\/bit.ly\/3STtH6f."},{"key":"2290487","doi-asserted-by":"crossref","unstructured":"Cheng YH, Tsao YC, Tzeng IS, Chuang HH, Li WC, Tung TH, et al. Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese. Medicine (Baltimore). 2017; 96(39):e8126. https:\/\/doi.org\/10.1097\/MD.0000000000008126.","DOI":"10.1097\/MD.0000000000008126"},{"key":"2290488","doi-asserted-by":"crossref","unstructured":"Darsini D, Hamidah H, Notobroto HB, Cahyono EA. Health risks associated with high waist circumference: A systematic review. J Public Health Res. 2020; 9(2):1811. https:\/\/doi.org\/10.4081\/jphr.2020.1811.","DOI":"10.4081\/jphr.2020.1811"},{"key":"2290489","unstructured":"D\u00edaz O, Hern\u00e1ndez J, Dom\u00ednguez E, Mart\u00ednez I, Bosch Y, del Busto A, et al. Valor de corte de la circunferencia de la cintura como predictor de disglucemia. Rev Cubana Endocrinol [Internet]. 2017 [citado 2022 Mayo 14]; 28(1). https:\/\/bit.ly\/42TyHfI."},{"key":"2290490","doi-asserted-by":"crossref","unstructured":"Hu FB, Stampfer MJ. Insulin resistance and hypertension: the chicken-egg question revisited. Circulation [Internet]. 2005 [citado 2023 Ago 24]; 112(12):1678\u201380. Disponible en: https:\/\/dx.doi.org\/10.1161\/CIRCULATIONAHA.105.568055.","DOI":"10.1161\/CIRCULATIONAHA.105.568055"},{"key":"2290491","doi-asserted-by":"crossref","unstructured":"Zhang T, Zhang H, Li S, Li Y, Liu Y, Fernandez C, et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: Longitudinal observation from the Bogalusa Heart Study. Hypertension. 2016; 67(1):56-62. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06509.","DOI":"10.1161\/HYPERTENSIONAHA.115.06509"},{"key":"2290492","unstructured":"Ministerio de Salud P\u00fablica. Direcci\u00f3n nacional de estad\u00edsticas y registros m\u00e9dicos. Anuario estad\u00edstico de salud 2021. La Habana: Ministerio de Salud P\u00fablica [Internet]; 2022. [citado 2023 Jun 16]. Disponible en: https:\/\/bit.ly\/3Tf9KZ2."},{"key":"2290493","unstructured":"Bonet M, Varona P, Chang M, Garc\u00eda RG, Suarez R, Arc\u00eda N, et al. III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011 [Internet]. 2014 [cita- do 2022 Mayo 14]. Disponible en: https:\/\/bit.ly\/48wyYXs."},{"key":"2290494","unstructured":"D\u00edaz-S\u00e1nchez ME, Maldonado G, Su\u00e1rez-Medina R, Varona P. Nuevos datos sobre el sobrepeso y la obesidad en Cuba. 2022 [Internet] [citado 2023 Jun 15]. Disponible en: https:\/\/bit.ly\/3SN7CWU."},{"key":"2290495","unstructured":"Ministerio de Salud P\u00fablica. Direcci\u00f3n nacional de estad\u00edsticas y registros m\u00e9dicos. Anuario estad\u00edstico de salud 2020. La Habana: Ministerio de Salud P\u00fablica [Internet]; 2021 [citado 2023 Jun 16]. Disponible en: https:\/\/bit.ly\/3IbZn1Y."},{"key":"2290496","doi-asserted-by":"crossref","unstructured":"Ortega MA, Fraile-Mart\u00ednez O, Naya I, Garc\u00eda-Honduvilla N, \u00c1lvarez-Mon M, Buj\u00e1n J, et al. Type 2 diabetes mellitus associated with obesity (diabesity). The central role of gut microbiota and its translational applications. Nutrients. 2020; 12(9):2749. http:\/\/dx.doi.org\/10.3390\/nu12092749.","DOI":"10.3390\/nu12092749"},{"key":"2290497","doi-asserted-by":"crossref","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, et al.; American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of care in Diabetes-2023. Diab Care. 2023;46 Suppl 1:S19- 40. https:\/\/doi.org\/10.2337\/dc23-S002.","DOI":"10.2337\/dc23-er05"},{"key":"2290498","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison-Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/ APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines. Hypertension. 2018; 71(6):1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066.","DOI":"10.1161\/HYP.0000000000000075"},{"key":"2290499","unstructured":"Arranz-Calzado C, Gonz\u00e1lez-Su\u00e1rez RM, \u00c1lvarez-\u00c1lvarez A, Rodr\u00edguez-Pend\u00e1s B, Reyes-Dur\u00e1n A. Criterios de referencia para los indicadores de secreci\u00f3n de insulina y de los par\u00e1metros lip\u00eddicos en una poblaci\u00f3n mixta hospitalaria. Rev Cubana Endocrinol [Internet]. 2010 [citado 2022 Mayo 14]; 21(1):1-12. Disponible en: https:\/\/bit.ly\/49vrlSb."},{"key":"2290500","doi-asserted-by":"crossref","unstructured":"Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: Latest trends. Curr Obes Rep. 2018; 7(4):276\u201388. https:\/\/dx.doi.org\/10.1007\/s13679-018-0317-8.","DOI":"10.1007\/s13679-018-0317-8"},{"key":"2290501","doi-asserted-by":"crossref","unstructured":"Qing L, Wei R, Chan L, Xiaoya Z, Xin X. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency. J Endo- crinol Invest. 2017; 40(6):653\u201361. https:\/\/dx.doi.org\/10.1007\/s40618-017-0621-2.","DOI":"10.1007\/s40618-017-0621-2"},{"key":"2290502","doi-asserted-by":"crossref","unstructured":"Zeng J, Lawrence WR, Yang J, Tian J, Li C, Lian W, et al. Association between serum uric acid and obesity in Chinese adults: a 9-year longitudinal data analysis. BMJ Open. 2021; 11(2):e041919. https:\/\/doi.org\/10.1136\/bmjopen-2020-041919.","DOI":"10.1136\/bmjopen-2020-041919"},{"key":"2290503","unstructured":"Delgado-Acosta H, Lastre-Navarro K, Vald\u00e9s-G\u00f3mez M, Benet-Rodr\u00edguez M, Morej\u00f3n-Giraldoni AF, Zerquera-Rodr\u00edguez J. Prevalencia de hipertensi\u00f3n arterial en el \u00c1rea I del municipio Cienfuegos. Segunda medici\u00f3n de la iniciativa CARMEN: cifras alarmantes. Rev Finlay [Internet]. 2015 [citado 2022 Mayo 14]; 5(1):4-11. Disponible en: https:\/\/bit.ly\/49QVNGo."},{"key":"2290504","doi-asserted-by":"crossref","unstructured":"Miguel-Soca PE, Rivas-Est\u00e9vez M, Sarmiento-Teruel Y, Mari\u00f1o-Soler AL, Marrero-Hidalgo M, Mosqueda-Batista L, et al. Prevalence of metabolic syndrome risk factors in adults in Holgu\u00edn, Cuba (2004-2013). MEDICC Rev. 2016; 18(1\u20132):28. https:\/\/doi.org\/10.37757\/MR2020.V22.N3.3.","DOI":"10.37757\/MR2016.V18.N1-2.6"},{"key":"2290505","unstructured":"Wong-McClure RA, Gregg EW, Barcel\u00f3 A, Lee K, Abarca-G\u00f3mez L, Sanabria-L\u00f3pez L, et al. Prevalence of metabolic syndrome in Central America: a cross-sectional population-based study. Rev Panam Salud Publica [Internet] 2015 [citado 2022 Mayo 14]; 38(3):202\u20138. Disponible en: https:\/\/bit.ly\/42Y8wow."},{"key":"2290506","doi-asserted-by":"crossref","unstructured":"Ord\u00fa\u00f1ez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA, et al. Blacks and whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health. 2013; 13(1):169. http:\/\/dx.doi.org\/10.1186\/1471-2458-13-169.","DOI":"10.1186\/1471-2458-13-169"},{"key":"2290507","unstructured":"Montoya Rodr\u00edguez MA. Acantosis nigricans como factor asociado a hipertensi\u00f3n arterial en pacientes del Hospital Bel\u00e9n de Trujillo. Universidad Privada Antenor Orrego-UPAO; [Internet]. 2020 [citado 2023 Ago 24]. Disponible en: https:\/\/bit.ly\/3OUJWPy."},{"key":"2290508","doi-asserted-by":"crossref","unstructured":"Da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: Metabolic syndrome revisited. Can J Cardiol. 2020; 36(5):671\u201382. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.066.","DOI":"10.1016\/j.cjca.2020.02.066"},{"key":"2290509","doi-asserted-by":"crossref","unstructured":"Mancusi C, Izzo R, di Gioia G, Losi MA, Barbato E, Morisco C. Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Press Cardiovasc Prev [Internet]. 2020; 27(6):515\u201326. https:\/\/doi.org\/10.1007\/s40292-020-00408-8.","DOI":"10.1007\/s40292-020-00408-8"}],"container-title":["Revista de Salud P\u00fablica"],"original-title":[],"link":[{"URL":"https:\/\/revistas.unal.edu.co\/index.php\/revsaludpublica\/article\/download\/110831\/91472","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistas.unal.edu.co\/index.php\/revsaludpublica\/article\/download\/110831\/91472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:37:22Z","timestamp":1728304642000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistas.unal.edu.co\/index.php\/revsaludpublica\/article\/view\/110831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.15446\/rsap.v25n6.110831","relation":{},"ISSN":["2539-3596","0124-0064"],"issn-type":[{"value":"2539-3596","type":"electronic"},{"value":"0124-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}